Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17698695 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Biological: BHT-3009-01

Indicates status has not been verified in more than two years